Principal Investigator: Dr Rizwan Uppal

Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy

Principal Investigator: Dr Rizwan Uppal

COVID-19 Transmission via Fomites at Low Temperature: A Potential Silent SARS-CoV-2 Propagation Route

Principal Investigator: Dr Rizwan Uppal

Azithromycin Treatment for SARS-CoV-2-related COVID-19 Pandemic Could Worsen Extensively Drug Resistant (XDR) Typhoid: A Risk of Losing the Last Bullet Against Salmonella enterica Serovar Typhi.

Principal Investigator: Dr Rizwan Uppal

Effectivity Analysis of SARS-CoV-2 Nasopharyngeal Swab Rapid Testing Kits in Pakistan: A Scenario of Inadequate COVID-19 Diagnosis.

Principal Investigator: Dr Rizwan Uppal

Evaluation of SARS-CoV-2 spike antibody levels among Sputnik V first dose vaccinated people in Pakistan: formulation of national anti-COVID-19 mass vaccination strategy.

Principal Investigator: Ms Sara Rizwan Uppal

Dermatomycoses in Pakistan; an urgent need for National Surveillance Programs

Principal Investigator: Dr Rizwan Uppal

Evaluation of Epidemic Prevention Abilities for Severe Acute Respiratory Syndrome Coronavirus-2 and Middle East Respiratory Syndrome Coronavirus in South Korea

Principal Investigator: Dr Rehan Uppal

SARS-CoV-2-Associated CRP, DD, FER, HBA1c, IL6, LDH, PBNP, and PCT Biomarkers and High-Resolution Computed Tomography During the First Three Waves of COVID-19 in Pakistan (2019-2021)

Principal Investigator: Dr Rizwan Uppal

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People

Principal Investigator: Dr Rizwan Uppal

Extensively Drug Resistant Salmonella Enterica Serovar Typhi Misdiagnosis in Pakistan: A Matter of Serious Concern

Principal Investigator: Dr Rizwan Uppal

Contemplating SARS-CoV-2 infectivity with respect to ABO blood groups

Principal Investigator: Dr Rizwan Uppal

SARS-CoV-2 related HIV, HBV, RSV, VZV, Enteric viruses, Infl uenza, DENV,S. aureus and TB co-infections